Latest Westinghouse Solar Inc (WEST) Headlines Andalay

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Latest Westinghouse Solar Inc (WEST) Headlines

Andalay Solar Announces Fourth Quarter and Year-End 2013 Results
PR Newswire - Thu Feb 27, 6:43AM CST
Andalay Solar, Inc. (OTCQB:WEST), a designer and manufacturer of solar power systems, today announced its fourth quarter and full year 2013 financial results.

Andalay Solar Announces Five-Fold Sequential Revenue Growth in Fourth Quarter
PR Newswire - Mon Feb 10, 6:48AM CST
Andalay Solar, Inc. (OTCQB: WEST) today announced its revenue results for the fourth quarter of 2013 as compared to the third quarter of 2013. Net revenue for the fourth quarter of 2013 was $757,000, an increase of $600,000 or 382% compared to the third quarter of 2013.

Zep Solar Acquisition Affirms Value of Integrated Solar Mounting Systems
PR Newswire - Tue Oct 15, 10:15AM CDT
Andalay Solar, Inc. (OTCQB: WEST) today congratulates SolarCity Corp. on its acquisition of Zep Solar, Inc., a provider of solar mounting systems in the U.S. As previously announced on October 9, 2013, SolarCity and Zep Solar entered into a definitive agreement for SolarCity to acquire Zep Solar, Inc. for approximately $158 million.

Westinghouse Solar's Transition Accelerates
PR Newswire - Tue Sep 10, 6:43AM CDT
Westinghouse Solar, Inc. (OTCQB:WEST), d/b/a Andalay Solar, announced today that as part of implementing its planned transition to a leading provider of innovative residential and commercial solar power systems, it began receiving product from its new supplier and has fulfilled and shipped back orders to customers. The Company also reported that it is on schedule to receive additional product from its supplier with a revenue value of $800,000 that it expects to ship to customers by the end of the fourth quarter of this year.

Westinghouse Solar Announces Supply Agreement with Environmental Engineering Group Pty Ltd
PR Newswire - Thu May 30, 6:16AM CDT
Westinghouse Solar, Inc. (OTCQB:WEST), a designer and manufacturer of integrated rooftop solar power systems, and Environmental Engineering Group Pty Ltd (EEG), today announced a Supply Agreement for the assembly of Westinghouse Solar's proprietary solar modules. EEG is an assembler of polycrystalline modules located in Stapylton, Australia, and a preferred supplier of CBD Energy Limited (ASX:CBD). As previously announced, Westinghouse Solar is working towards completing a merger with CBD in 2013.

Westinghouse Solar, Inc. Signs Sub-License with CBD Energy Limited
PR Newswire - Mon Apr 22, 6:00AM CDT
Westinghouse Solar, Inc. (OTCQB: WEST), a designer and manufacturer of integrated rooftop solar power systems and CBD Energy Limited (ASX: CBD), a diversified renewable energy company, have negotiated a sub-license for use of the Westinghouse Solar brand and technologies in Australia.

Intra-Day Stocks in Focus: (OTCQB: WEST), (NASDAQ: BGCP)
ACCESSWIRE-TNW - Fri Feb 15, 12:31PM CST
New York (February 15th, 2013) - Westinghouse Solar Inc. (OTCQB: WEST) opened at $0.13 and oscillated in the range of $0.08 and $0.13 in the latest trading session. It is at $0.09, down 23.36 percent from its previous close of $0.12. Westinghouse Solar shows bearish trend and the stock's first resistance level is at $0.10. On the downside, it may slip to $0.08. Upon breaching this level, the stock may touch $0.05. Westinghouse Solar traded 5.142 million shares so far.

Andalay Solar Inc. (WEST) Stock Research Links

WEST Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 24

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 18

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 21

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 34

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 26

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 27

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading

Top 5 Most Recently Viewed Articles

Boeing Aims to Raise $25 Billion Through Stock and Debt Sales

Updated Category News Views 83

Boeing's Strategic Move to Raise Funds Boeing recently filed a registration statement with U.S. market regulators to raise up to $25 billion through a mix of debt securities and stock offerings. This decision comes as the company aims to shore up its financial resources amid considerable debt maturities on the horizon. Financial Context for the Offering Though the...

Continue Reading
Novartis Achieves Strong Q2 Growth with Enhanced Guidance for 2025

Updated Category News Views 628

Impressive Q2 Financial Results from Novartis Novartis has recently shared its stellar performance for the second quarter, showcasing remarkable growth tantamount to an impressive 11% increase in net sales when accounting for constant currencies and a 12% increase in USD. Core operating income soared by 21%, reflecting a robust business framework and strategic focus on...

Continue Reading
Insightful Fireside Chat on Upexi's Future Strategies Ahead

Updated Category News Views 85

Upexi to Host Engaging Fireside Chat with Leadership Team Upexi, Inc. (NASDAQ: UPXI), a dynamic player in the consumer products and cryptocurrency sectors, has officially announced an upcoming fireside chat featuring its CEO, Allan Marshall, and Chief Strategy Officer, Brian Rudick. This event is set to take place on an upcoming Thursday at 11:00 a.m. ET, aiming to delve...

Continue Reading
Genius Group Faces Securities Law Violations Claims

Updated Category News Views 20

Another Day, Another Lawsuit: Genius Group's Legal Trouble Step right up, folks, it's time for the latest courtroom drama involving Genius Group Limited (NYSE American: GNS). You know the drill. A company gets too cocky, spouts off a bunch of bloated nonsense, and now they're knee-deep in securities law muck. This time it's Genius, and the folks at DJS Law Group are...

Continue Reading
Understanding Chart Industries' Stock Sentiment and Trends

Updated Category News Views 141

The Current Sentiment for Chart Industries Chart Industries, renowned for its innovation in energy and industrial gas solutions, has recently seen intriguing shifts in its stock dynamics. As of the latest report, the short percent of float for Chart Industries (GTLS) has notably decreased by 25.37%. This decline highlights that investors may be gaining confidence in the...

Continue Reading